X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1473) 1473
Publication (25) 25
Book Review (3) 3
Book Chapter (2) 2
Conference Proceeding (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (814) 814
female (802) 802
male (778) 778
nitrosourea compounds - administration & dosage (743) 743
animals (714) 714
middle aged (435) 435
adult (379) 379
nitrosourea compounds - therapeutic use (374) 374
rats (355) 355
aged (336) 336
mice (312) 312
oncology (257) 257
antineoplastic combined chemotherapy protocols - therapeutic use (247) 247
antineoplastic agents - administration & dosage (217) 217
drug therapy, combination (216) 216
nitrosourea compounds - adverse effects (204) 204
antineoplastic agents - therapeutic use (202) 202
time factors (191) 191
brain neoplasms - drug therapy (178) 178
nimustine (158) 158
nitrosourea compounds - toxicity (157) 157
drug administration schedule (142) 142
dose-response relationship, drug (138) 138
melanoma - drug therapy (137) 137
chemotherapy (136) 136
organophosphorus compounds - administration & dosage (126) 126
neoplasms, experimental - chemically induced (125) 125
nitrosourea compounds - pharmacology (125) 125
index medicus (122) 122
vincristine - administration & dosage (116) 116
combined modality therapy (109) 109
cyclophosphamide - administration & dosage (105) 105
adolescent (100) 100
lung neoplasms - drug therapy (99) 99
antineoplastic agents - adverse effects (98) 98
doxorubicin - administration & dosage (97) 97
rats, inbred strains (97) 97
lomustine - administration & dosage (93) 93
glioma - drug therapy (92) 92
nitrosourea compounds (90) 90
drug evaluation (86) 86
fluorouracil - administration & dosage (86) 86
pregnancy (85) 85
clinical trials as topic (82) 82
administration, oral (80) 80
cancer (77) 77
neoplasm metastasis (76) 76
neoplasm transplantation (76) 76
dacarbazine - administration & dosage (75) 75
prognosis (74) 74
treatment outcome (74) 74
injections, intravenous (72) 72
carcinogens (70) 70
fotemustine (70) 70
semustine - administration & dosage (70) 70
methylnitrosourea - administration & dosage (66) 66
adenocarcinoma - drug therapy (65) 65
organophosphorus compounds - adverse effects (65) 65
bone marrow - drug effects (61) 61
neoplasms, experimental - drug therapy (61) 61
methotrexate - administration & dosage (60) 60
antineoplastic combined chemotherapy protocols - adverse effects (59) 59
child (59) 59
glioblastoma - drug therapy (59) 59
lomustine - therapeutic use (59) 59
methylnitrosourea - toxicity (59) 59
brain neoplasms - therapy (58) 58
organophosphorus compounds - therapeutic use (58) 58
thrombocytopenia - chemically induced (58) 58
etoposide - administration & dosage (57) 57
brain neoplasms - chemically induced (55) 55
pharmacology & pharmacy (55) 55
antineoplastic combined chemotherapy protocols - administration & dosage (54) 54
skin neoplasms - drug therapy (52) 52
brain neoplasms - pathology (50) 50
colonic neoplasms - drug therapy (50) 50
brain neoplasms - radiotherapy (49) 49
carmustine - administration & dosage (49) 49
cyclophosphamide - therapeutic use (49) 49
drug synergism (49) 49
mice, inbred strains (49) 49
neoplasms - drug therapy (49) 49
leukopenia - chemically induced (48) 48
mammary neoplasms, experimental - chemically induced (48) 48
rats, inbred f344 (48) 48
neoplasms, experimental - pathology (47) 47
nitrosourea (47) 47
leukemia l1210 - drug therapy (46) 46
nitrosourea compounds - metabolism (46) 46
melanoma - secondary (45) 45
remission, spontaneous (45) 45
survival analysis (45) 45
melanoma - pathology (44) 44
survival rate (44) 44
carmustine - therapeutic use (43) 43
follow-up studies (43) 43
prednisolone - administration & dosage (42) 42
semustine - therapeutic use (42) 42
vincristine - therapeutic use (42) 42
cisplatin - administration & dosage (41) 41
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1165) 1165
Japanese (201) 201
German (35) 35
French (32) 32
Russian (30) 30
Italian (3) 3
Polish (2) 2
Portuguese (2) 2
Spanish (2) 2
Chinese (1) 1
Croatian (1) 1
Dutch (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 03/2014, Volume 25, Issue 3, pp. 742 - 746
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 879 - 886
Journal Article
MEDICINE, ISSN 0025-7974, 07/2018, Volume 97, Issue 27, p. e11254
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 11/2018, Volume 140, Issue 2, pp. 427 - 434
This prospective, randomized, controlled and open-label clinical trial sought to evaluate the tolerability and efficacy of the FTD regimen (fotemustine,... 
Primary CNS lymphoma | Neurology | Chemotherapy | Medicine & Public Health | Oncology | Teniposide | Methotrexate | Whole-brain radiotherapy | SURVIVAL | RADIATION | CLINICAL NEUROLOGY | IRRADIATION | B-CELL LYMPHOMA | THERAPY | ONCOLOGY | RITUXIMAB | PROGNOSTIC-SIGNIFICANCE | NERVOUS-SYSTEM LYMPHOMA | Nitrosourea Compounds - administration & dosage | Nitrosourea Compounds - adverse effects | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - administration & dosage | Cytarabine - adverse effects | Lymphoma - mortality | Lymphoma - metabolism | Teniposide - adverse effects | Young Adult | Lymphoma - drug therapy | Antineoplastic Agents - adverse effects | Proto-Oncogene Proteins c-bcl-6 - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Central Nervous System Neoplasms - metabolism | Organophosphorus Compounds - adverse effects | Dexamethasone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols | Treatment Outcome | Teniposide - administration & dosage | Cytarabine - administration & dosage | Methotrexate - adverse effects | Adolescent | Methotrexate - administration & dosage | Aged | Organophosphorus Compounds - administration & dosage | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Dexamethasone | Analysis | Clinical trials | Lymphomas | Dosage and administration | Product development | Steroids | Cancer | Central nervous system | Radiation therapy | Lymphoma | Survival | Cytarabine | Frontotemporal dementia | Bcl-6 protein | Neutropenia | Clinical Study
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2016, Volume 172, Issue 1, pp. 111 - 121
Summary High‐dose chemotherapy (HDT) with autologous stem cell transplantation is the standard of care for relapsed/refractory (RR) Hodgkin lymphoma (HL).... 
high‐dose chemotherapy | fotemustine | autologous stem cell transplantation | Hodgkin lymphoma | High-dose chemotherapy | Autologous stem cell transplantation | Fotemustine | FDG-PET | fote-mustine | PULMONARY TOXICITY | PROGNOSTIC-FACTORS | BONE-MARROW-TRANSPLANTATION | STEM-CELL-TRANSPLANTATION | BRENTUXIMAB VEDOTIN | PREPARATIVE REGIMENS | RANDOMIZED-TRIAL | CONDITIONING REGIMEN | SALVAGE THERAPY | HEMATOLOGY | high-dose chemotherapy | Drug Evaluation - methods | Hodgkin Disease - diagnostic imaging | Nitrosourea Compounds - administration & dosage | Nitrosourea Compounds - adverse effects | Salvage Therapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Cytarabine - adverse effects | Young Adult | Melphalan - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Registries | Transplantation Conditioning - methods | Child | Organophosphorus Compounds - adverse effects | Etoposide - adverse effects | Kaplan-Meier Estimate | Etoposide - administration & dosage | Graft Survival | Treatment Outcome | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Aged | Organophosphorus Compounds - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Chemotherapy | Lymphomas | Patient outcomes | Stem cells | Cancer | Index Medicus | Research Paper | Haematological Malignancy
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2010, Volume 16, Issue 8, pp. 2352 - 2362
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2277 - 2288
Purpose: The MHC-unrestricted activity of cytokine-induced killer (CIK) cells against chemo-surviving melanoma cancer stem cells (mCSC) was explored, as CSCs... 
METASTATIC MELANOMA | ONCOLOGY | LENTIVIRUS VECTOR | IN-VIVO | THERAPY RESISTANCE | OPEN-LABEL | ACUTE MYELOID-LEUKEMIA | HLA BARRIERS | CIK CELLS | ANTITUMOR-ACTIVITY | CD8(+) T-CELLS | Nitrosourea Compounds - administration & dosage | Humans | Oximes - administration & dosage | Imidazoles - administration & dosage | Neoplastic Stem Cells - immunology | Lentivirus - genetics | Immunotherapy, Adoptive - methods | Carcinogenesis - immunology | Carcinogenesis - genetics | Neoplasm Recurrence, Local | Drug Resistance, Neoplasm - immunology | Melanoma - pathology | Neoplastic Stem Cells - transplantation | Cytokine-Induced Killer Cells - immunology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Melanoma - immunology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cytokine-Induced Killer Cells - transplantation | Cell Line, Tumor | Mice | Organophosphorus Compounds - administration & dosage | Melanoma - therapy | Cytotoxicity, Immunologic | Autografts | Animal models | Cytokines | Oct-4 protein | Immunodeficiency | Melanoma | Chemoresistance | Stem cell transplantation | Gene expression | Anticancer properties | Infusion | Design engineering | Killer cells | Chemotherapy | Dilution | Major histocompatibility complex | Allografts | Experimental design | Immunotherapy | Stem cells | Lysis | Xenografts | Antitumor activity | Cancer
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2018, Volume 18, Issue 1, pp. 552 - 8
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2010, Volume 16, Issue 23, pp. 5862 - 5872
Journal Article